Yamamoto S, Romanenko A, Wei M, Masuda C, Zaparin W, Vinnichenko W, Vozianov A, Lee C C, Morimura K, Wanibuchi H, Tada M, Fukushima S
Department of Pathology, Osaka City University Medical School, Osaka, Japan.
Cancer Res. 1999 Aug 1;59(15):3606-9.
After the Chernobyl accident, the incidence of urinary bladder cancers in the Ukraine population increased gradually from 26.2 to 36.1 per 100,000 between 1986 and 1996. Urinary bladder epithelium biopsied from 45 male patients with benign prostatic hyperplasia living in radiocontaminated areas of Ukraine demonstrated frequent severe urothelial dysplasia, carcinoma in situ, and a single invasive transitional cell carcinoma, combined with irradiation cystitis in 42 cases (93%). No neoplastic changes (carcinoma in situ or transitional cell carcinoma) were found in 10 patients from clean areas (areas without radiocontamination). DNA was extracted from the altered urothelium of selected paraffin-embedded specimens that showed obviously abnormal histology (3 cases) or intense p53 immunoreactivity (15 cases), and mutational analysis of exons 5-8 of the p53 gene was performed by PCR-single-strand conformational polymorphism analysis followed by DNA sequencing. Nine of 17 patients (53%) had one or more mutations in the altered urothelium. Urine sediment samples were also collected from the patients at 4-27 months after biopsy and analyzed by PCR-single-strand conformational polymorphism analysis or yeast functional assay, and identical or additional p53 mutations were found in four of five cases. Interestingly, a relative hot spot at codon 245 was found in five of nine (56%) cases with mutations, and 11 of the 13 mutations determined (73%) were G:C to A:T transitions at CpG dinucleotides, reported to be relatively infrequent (approximately 18%) in human urinary bladder cancers. Therefore, the frequent and specific p53 mutations found in these male patients may alert us to a future elevated occurrence of urinary bladder cancers in the radiocontaminated areas.
切尔诺贝利事故后,乌克兰人群中膀胱癌的发病率在1986年至1996年间从每10万人26.2例逐渐增至36.1例。对居住在乌克兰放射性污染地区的45例良性前列腺增生男性患者的膀胱上皮进行活检,结果显示频繁出现严重的尿路上皮发育异常、原位癌和1例浸润性移行细胞癌,42例(93%)合并放射性膀胱炎。在来自清洁地区(无放射性污染地区)的10例患者中未发现肿瘤性改变(原位癌或移行细胞癌)。从选定的石蜡包埋标本的病变尿路上皮中提取DNA,这些标本显示出明显异常的组织学特征(3例)或强烈的p53免疫反应性(15例),并通过聚合酶链反应-单链构象多态性分析随后进行DNA测序对p53基因外显子5-8进行突变分析。17例患者中有9例(53%)在病变尿路上皮中有一个或多个突变。在活检后4-27个月还从患者中收集尿沉渣样本,并通过聚合酶链反应-单链构象多态性分析或酵母功能测定进行分析,在5例中的4例中发现了相同或额外的p53突变。有趣的是,在9例(56%)有突变的病例中有5例在密码子245处发现了一个相对热点,在确定的13个突变中有11个(73%)是CpG二核苷酸处的G:C到A:T转换,据报道在人类膀胱癌中相对少见(约18%)。因此,在这些男性患者中发现的频繁且特定的p53突变可能提醒我们,放射性污染地区未来膀胱癌的发病率会升高。